- Filed
- May 14, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 7, 2020 | 7.95M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 8.09M sh |
| Shares Diluted restated | Q1 2020 · Mar 31, 2019 | 7.66M sh |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | $1.28M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $8.31M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $1.74M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $904K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2019 | $11.02M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2018 | $5.74M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $60.07M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $50.07M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $40.8M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $48.72M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $36.03M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $26.27M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $308.39M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $298.25M |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | $1.20 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | −$0.54 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | $1.25 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | −$0.54 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $3.3M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $4.69M |
| Net Income | Q1 2020 · Mar 31, 2020 | $9.8M |
| Net Income restated | Q1 2020 · Mar 31, 2019 | −$4.1M |
| Operating Income | Q1 2020 · Mar 31, 2020 | $18.75M |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$3.8M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $2.58M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $1.67M |
| Revenue | Q1 2020 · Mar 31, 2020 | $42.47M |
| Revenue | Q1 2020 · Mar 31, 2019 | $24.95M |